Delayed Cytoreductive Nephrectomy Following Three Years of Targeted Therapy for Metastatic Renal Cell Carcinoma

Publisher： Karger

E-ISSN： 1661-7657|9|4|202-208

ISSN： 1661-7649

Source： Current Urology, Vol.9, Iss.4, 2016-12, pp. : 202-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Performing Cytoreductive Nephrectomy following Targeted Sunitinib Therapy for Metastatic Renal Cell Carcinoma: A Surgical Perspective

By  

Urologia Internationalis, Vol. 89, Iss. 1, 2012-05 ,pp. : 83-88

Karger

Access to resources Recommend Favorite

Cytokine Therapy Response as a Selection Criterion for Cytoreductive Nephrectomy in Metastatic Renal Clear-Cell Carcinoma of Intermediate Prognosis

By  

Urologia Internationalis, Vol. 80, Iss. 4, 2008-06 ,pp. : 367-371

Karger

Access to resources Recommend Favorite

Role of cytoreductive nephrectomy for Japanese patients with primary renal cell carcinoma in the cytokine and targeted therapy era

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 8, 2015-08 ,pp. : 736-740

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial Comment to Role of cytoreductive nephrectomy for Japanese patients with primary renal cell carcinoma in the cytokine and targeted therapy era

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 8, 2015-08 ,pp. : 740-741

John Wiley & Sons Inc

Access to resources Recommend Favorite

Duration of Targeted Therapy for Metastatic Renal Cell Carcinoma: A Review of Current Practices

By  

Oncology, Vol. 82, Iss. 4, 2012-03 ,pp. : 189-196

Karger

Access to resources Recommend Favorite